• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆级联系统在骨缺血/再灌注损伤中的作用。

Role of the plasma cascade systems in ischemia/reperfusion injury of bone.

作者信息

Zhang Shengye, Wotzkow Carlos, Bongoni Anjan K, Shaw-Boden Jane, Siegrist Mark, Taddeo Adriano, Blank Fabian, Hofstetter Willy, Rieben Robert

机构信息

Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland; Department of Clinical Research, University of Bern, Bern, Switzerland.

Department of Clinical Research, University of Bern, Bern, Switzerland.

出版信息

Bone. 2017 Apr;97:278-286. doi: 10.1016/j.bone.2016.12.007. Epub 2017 Jan 31.

DOI:10.1016/j.bone.2016.12.007
PMID:28159709
Abstract

Ischemia/reperfusion (I/R) injury has been extensively studied in organs such as heart, brain, liver, kidney, and lung. As a vascularized organ, bone is known to be susceptible to I/R injury too, but the respective mechanisms are not well understood to date. We therefore hypothesized that, similar to other organs, plasma cascade-induced inflammation also plays a role in bone I/R injury. Reperfusion injury in rat tibia was induced by unilateral clamping of the femoral artery and additional use of a tourniquet, while keeping the femoral vein patent to prevent venous congestion. Rats were subjected to 4h ischemia and 24h reperfusion. Deposition of complement fragment C3b/c and fibrin as well as expression of tissue factor (TF), tissue plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1), and E-selectin was detected by immunohistochemistry. In plasma, the levels of high mobility group box1 (HMGB1) were measured by ELISA. The total level of complement in serum was assessed by the CH50 test. Our results show that deposition of C3b/c was significantly increased with respect to healthy controls in cortical bone as well as in marrow of reperfused limbs. C3b/c deposition was also increased in cortical bone, but not in bone marrow, of contralateral limbs. Deposition of fibrin, as well as expression of PAI-1, was significantly increased in bone after ischemia and reperfusion, whereas expression of tPA was reduced. These differences were most prominent in vessels of bone, both in marrow and cortical bone, and both in reperfused and contralateral limbs. However, PAI-1, was only increased in vessels of reperfused cortical bone and there were no significant changes in expression of E-selectin. With respect to solid bone tissue, a significant increase of C3b/c and fibrin deposition was shown in osteocytes, and for fibrin also in the bone matrix, in both contralateral and reperfused cortical bone compared with normal healthy controls. A slight expression of TF was visible in osteocytes of the normal healthy control group, while TF was not present in the experimental groups. Moreover, CH50 values in serum decreased over time and HMGB1 was significantly increased in plasma of animals at the end of reperfusion. We conclude that ischemia and reperfusion of bone leads to activation of the complement and coagulation systems and a downregulation of the fibrinolytic cascade. In the acute phase, a vascular inflammation induced by activation of the plasma cascade systems also occurs in the bone. This is similar to I/R injury of other vascularized organs and tissues.

摘要

缺血/再灌注(I/R)损伤已在心脏、脑、肝、肾和肺等器官中得到广泛研究。作为一个血管化器官,骨骼也已知易受I/R损伤影响,但其具体机制迄今尚未完全明确。因此,我们推测,与其他器官类似,血浆级联反应诱导的炎症在骨骼I/R损伤中也发挥作用。通过单侧夹闭股动脉并额外使用止血带来诱导大鼠胫骨的再灌注损伤,同时保持股静脉通畅以防止静脉淤血。大鼠经历4小时缺血和24小时再灌注。通过免疫组织化学检测补体片段C3b/c和纤维蛋白的沉积以及组织因子(TF)、组织纤溶酶原激活物(tPA)、纤溶酶原激活物抑制剂-1(PAI-1)和E-选择素的表达。在血浆中,通过酶联免疫吸附测定法(ELISA)测量高迁移率族蛋白B1(HMGB1)的水平。通过50%溶血补体(CH50)试验评估血清中的总补体水平。我们的结果表明,与健康对照组相比,再灌注肢体的皮质骨和骨髓中C3b/c的沉积显著增加。对侧肢体的皮质骨中C3b/c沉积也增加,但骨髓中未增加。缺血和再灌注后,骨骼中纤维蛋白的沉积以及PAI-1的表达显著增加,而tPA的表达降低。这些差异在骨髓和皮质骨的骨血管中最为明显,在再灌注肢体和对侧肢体中均如此。然而,PAI-1仅在再灌注皮质骨的血管中增加,E-选择素的表达无显著变化。对于实体骨组织,与正常健康对照组相比,对侧和再灌注皮质骨的骨细胞中C3b/c和纤维蛋白沉积显著增加,纤维蛋白在骨基质中也增加。正常健康对照组的骨细胞中可见轻微的TF表达,而实验组中未检测到TF。此外,血清中的CH50值随时间下降,再灌注结束时动物血浆中的HMGB1显著增加。我们得出结论,骨骼的缺血和再灌注导致补体和凝血系统激活以及纤维蛋白溶解级联反应下调。在急性期,血浆级联系统激活诱导的血管炎症也发生在骨骼中。这与其他血管化器官和组织的I/R损伤相似。

相似文献

1
Role of the plasma cascade systems in ischemia/reperfusion injury of bone.血浆级联系统在骨缺血/再灌注损伤中的作用。
Bone. 2017 Apr;97:278-286. doi: 10.1016/j.bone.2016.12.007. Epub 2017 Jan 31.
2
Effects of C1 inhibitor on endothelial cell activation in a rat hind limb ischemia-reperfusion injury model.C1抑制剂对大鼠后肢缺血再灌注损伤模型中内皮细胞活化的影响。
J Vasc Surg. 2018 Dec;68(6S):209S-221S.e2. doi: 10.1016/j.jvs.2017.10.072. Epub 2018 Feb 1.
3
Use of dextran sulfate in tourniquet-induced skeletal muscle reperfusion injury.右旋糖酐硫酸酯在止血带诱导的骨骼肌再灌注损伤中的应用。
J Surg Res. 2014 Mar;187(1):150-61. doi: 10.1016/j.jss.2013.10.012. Epub 2013 Oct 12.
4
Enhancement of endogenous fibrinolysis does not reduce local fibrin deposition, but modulates inflammation upon intestinal ischemia and reperfusion.增强内源性纤维蛋白溶解作用并不会减少局部纤维蛋白沉积,但会调节肠道缺血再灌注后的炎症反应。
Thromb Haemost. 2004 Mar;91(3):497-505. doi: 10.1160/TH03-08-0529.
5
Effect of C1-INH on ischemia/reperfusion injury in a porcine limb ex vivo perfusion model.C1抑制物对猪肢体离体灌注模型中缺血/再灌注损伤的影响。
Mol Immunol. 2017 Aug;88:116-124. doi: 10.1016/j.molimm.2017.06.021. Epub 2017 Jun 20.
6
Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.缺氧协同诱导纤溶酶原激活物抑制剂-1(PAI-1)并抑制纤溶酶原激活物基因表达,从而促进肺血管纤维蛋白沉积。
J Clin Invest. 1998 Sep 1;102(5):919-28. doi: 10.1172/JCI307.
7
Potentiation of endogenous fibrinolysis and rescue from lung ischemia/reperfusion injury in interleukin (IL)-10-reconstituted IL-10 null mice.白细胞介素(IL)-10 重组的 IL-10 基因敲除小鼠体内内源性纤维蛋白溶解的增强及肺缺血/再灌注损伤的挽救
J Biol Chem. 2000 Jul 14;275(28):21468-76. doi: 10.1074/jbc.M002682200.
8
Enhanced fibrinolysis protects against lung ischemia-reperfusion injury.增强的纤维蛋白溶解作用可预防肺缺血再灌注损伤。
J Thorac Cardiovasc Surg. 2009 May;137(5):1241-8. doi: 10.1016/j.jtcvs.2008.12.029.
9
C1 esterase inhibitor reduces lower extremity ischemia/reperfusion injury and associated lung damage.C1 酯酶抑制剂可减轻下肢缺血/再灌注损伤及相关肺损伤。
PLoS One. 2013 Aug 26;8(8):e72059. doi: 10.1371/journal.pone.0072059. eCollection 2013.
10
[Effects of acupoint-embedment of medicated-thread and acupoint-injection on expression of cortical urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in rats with cerebral ischemia-reperfusion injury].[药线穴位埋线与穴位注射对脑缺血再灌注损伤大鼠皮质尿激酶型纤溶酶原激活剂及纤溶酶原激活剂抑制剂-1表达的影响]
Zhen Ci Yan Jiu. 2010 Dec;35(6):409-14.

引用本文的文献

1
Managing Oxidative Stress Using Vitamin C to Improve Biocompatibility of Polycaprolactone for Bone Regeneration .利用维生素C控制氧化应激以提高聚己内酯对骨再生的生物相容性
ACS Omega. 2024 Jul 12;9(29):31776-31788. doi: 10.1021/acsomega.4c02858. eCollection 2024 Jul 23.
2
MicroRNAs as novel biomarkers and potential therapeutic options for inflammatory cardiomyopathy.微小 RNA 作为炎症性心肌病的新型生物标志物和潜在治疗选择。
ESC Heart Fail. 2023 Dec;10(6):3410-3418. doi: 10.1002/ehf2.14523. Epub 2023 Sep 7.
3
Synergetic protective effect of remote ischemic preconditioning and prolyl 4‑hydroxylase inhibition in ischemic cardiac injury.
远程缺血预处理和脯氨酰 4-羟化酶抑制在缺血性心脏损伤中的协同保护作用。
Mol Med Rep. 2022 Mar;25(3). doi: 10.3892/mmr.2022.12596. Epub 2022 Jan 14.
4
Comparison of two different biomaterials in the bone regeneration (15, 30 and 60 days) of critical defects in rats.比较两种不同生物材料在大鼠临界缺损骨再生中的应用(15、30 和 60 天)。
Acta Cir Bras. 2021 Jul 19;36(6):e360605. doi: 10.1590/ACB360605. eCollection 2021.
5
Bone biology in postnatal Wistar rats following hypoxia-reoxygenation.新生 Wistar 大鼠缺氧-复氧后骨生物学的变化。
Histol Histopathol. 2020 Jan;35(1):111-124. doi: 10.14670/HH-18-143. Epub 2019 Jul 3.
6
Microcirculatory consequences of limb ischemia/reperfusion in ovariectomized rats treated with zoledronic acid.唑来膦酸治疗的去卵巢大鼠肢体缺血/再灌注的微循环后果
J Orthop Surg Res. 2019 Apr 4;14(1):95. doi: 10.1186/s13018-019-1117-x.
7
High-Mobility Group Box-1 and Liver Disease.高迁移率族蛋白盒1与肝脏疾病
Hepatol Commun. 2018 Sep 7;2(9):1005-1020. doi: 10.1002/hep4.1223. eCollection 2018 Sep.